Cancer Expert Calls for Interdisciplinary Efforts at NCKU Conference - Education Drive
TAINAN, Taiwan--( BUSINESS WIRE )--Cancer genomics research expert Ilya Shmulevich, a professor of the Institute for Systems Biology (ISB), has called on computer scientists and biologists to work together in order to achieve a breakthrough in medical science.
“What's unique about the project is that for each tumor sample, they generate all of these data, DNA, RNA, protein, and that will give the potential power of the data analysis.”
Shmulevich was invited by National Cheng Kung University (NCKU), southern Taiwan, as a keynote speaker at GIW 2012 -- the 23 rd International Conference on Genome Informatics - to give a talk on "Integrative Analysis and Interactive Exploration of Data from The Cancer Genome Atlas (TCGA)," Dec. 13.
Shmulevich said, "TCGA data is large scale molecular measurement data from different cancers. They measure DNA, RNA and protein and so they generate lots of data from individual cancer patient from individual tumor, and they do that for approximately 25 different tumor types and then we compute and analyze all of these data and to learn about the cancer."
His work in cancer genomics research spans multiple cancers, with published work in glioma, lymphoma, leukemia, breast cancer, there ovarian cancer, and sarcoma. "Overall will be 10,000 cancer patients included in the project," said Shmulevich.
However, "TCGA project was not designed to do clinical research because we don't have enough information to make new clinical discovery," said Shmulevich.
He added, "The goal of the project is to provide molecular characterization of the cancer and these data will be used by other studies to make new clinical discoveries, new follow-up studies and probably clinical trials."
"TCGA is so powerful because it's unprecedented in its scope, and in its scope it turns out how much data it generates for different cancers," Dr. Shmulevich said. "There's never been a project including so many different kinds of data for cancers."
"What's unique about the project is that for each tumor sample, they generate all of these data, DNA, RNA, protein, and that will give the potential power of the data analysis."
Dr. Shmulevich offered his advice for students who are interested in the field: "For students of Computer Science and Engineering or Bioinformatics, I would strongly advise working collaboratively on projects with biologists."
He said, "You cannot just sit there analyzing those data without really understanding what they mean and that's the major limitation we have in the field. The important breakthrough is going to happen when people are working with interdisciplinary teams."
“What's unique about the project is that for each tumor sample, they generate all of these data, DNA, RNA, protein, and that will give the potential power of the data analysis.”
Shmulevich was invited by National Cheng Kung University (NCKU), southern Taiwan, as a keynote speaker at GIW 2012 -- the 23 rd International Conference on Genome Informatics - to give a talk on "Integrative Analysis and Interactive Exploration of Data from The Cancer Genome Atlas (TCGA)," Dec. 13.
Shmulevich said, "TCGA data is large scale molecular measurement data from different cancers. They measure DNA, RNA and protein and so they generate lots of data from individual cancer patient from individual tumor, and they do that for approximately 25 different tumor types and then we compute and analyze all of these data and to learn about the cancer."
His work in cancer genomics research spans multiple cancers, with published work in glioma, lymphoma, leukemia, breast cancer, there ovarian cancer, and sarcoma. "Overall will be 10,000 cancer patients included in the project," said Shmulevich.
However, "TCGA project was not designed to do clinical research because we don't have enough information to make new clinical discovery," said Shmulevich.
He added, "The goal of the project is to provide molecular characterization of the cancer and these data will be used by other studies to make new clinical discoveries, new follow-up studies and probably clinical trials."
"TCGA is so powerful because it's unprecedented in its scope, and in its scope it turns out how much data it generates for different cancers," Dr. Shmulevich said. "There's never been a project including so many different kinds of data for cancers."
"What's unique about the project is that for each tumor sample, they generate all of these data, DNA, RNA, protein, and that will give the potential power of the data analysis."
Dr. Shmulevich offered his advice for students who are interested in the field: "For students of Computer Science and Engineering or Bioinformatics, I would strongly advise working collaboratively on projects with biologists."
He said, "You cannot just sit there analyzing those data without really understanding what they mean and that's the major limitation we have in the field. The important breakthrough is going to happen when people are working with interdisciplinary teams."
Click Num:
Share
